# OsteoCool Tumor Ablation Post-Market Study

> **NCT03249584** · NA · COMPLETED · sponsor: **MedtronicNeuro** · enrollment: 218 (actual)

## Conditions studied

- Metastasis Spine
- Metastasis to Bone

## Interventions

- **DEVICE:** OsteoCool™ RF Ablation

## Key facts

- **NCT ID:** NCT03249584
- **Lead sponsor:** MedtronicNeuro
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-12
- **Primary completion:** 2019-04-30
- **Final completion:** 2020-07-17
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2021-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03249584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03249584, "OsteoCool Tumor Ablation Post-Market Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03249584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*